Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromsø Study.
about
Deficiency of the NR4A orphan nuclear receptor NOR1 in hematopoietic stem cells accelerates atherosclerosisMechanisms that regulate macrophage burden in atherosclerosis.Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older personsSuppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regressionLeukocyte subtype counts and its association with vascular structure and function in adults with intermediate cardiovascular risk. MARK study.NADPH oxidase 4 mediates monocyte priming and accelerated chemotaxis induced by metabolic stress.Glutaredoxin 2a overexpression in macrophages promotes mitochondrial dysfunction but has little or no effect on atherogenesis in LDL-receptor null mice.Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectinThe relationship between carotid intima-media thickness and carotid plaque in the Northern Manhattan Study.Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis.Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art.Association of albuminuria and cancer incidence.Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes.Emerging hematological targets and therapy for cardiovascular disease: From bench to bedsidePercutaneous Transluminal Angioplasty in Patients with Peripheral Arterial Disease Does Not Affect Circulating Monocyte Subpopulations.Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes.Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis.The prognostic values of leukocyte Rho kinase activity in acute ischemic strokeMonocytes and macrophages in cardiac injury and repair.Effects of dyslipidaemia on monocyte production and function in cardiovascular disease.Monocyte count-to-high-density lipoprotein-cholesterol ratio is associated with abdominal aortic aneurysm size.Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice.Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.The Tromsø study 1974-2016: 40 years of cardiovascular research.Monocyte mayhem: do subtypes modulate distinct atherosclerosis phenotypes?Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease.Monocyte count is an underlying marker of lacunar subtype of hypertensive small vessel disease.Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD.Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome.Surfactant protein-D deficiency suppresses systemic inflammation and reduces atherosclerosis in ApoE knockout mice.The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome.Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease.Blood monocyte count may be a predictor of vascular access failure in hemodialysis patients.Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis.
P2860
Q28513554-92A29236-AEA4-4ADE-9DF7-AD1A9AD8E71BQ33761114-5033755B-EB2E-4519-855A-C430F2F10ED9Q33819382-FD87CF33-81C5-4884-B9C2-533B84924D7CQ34138655-33739756-328D-44CF-8D0A-ECA8B2372BB9Q34876397-E69135ED-0D82-4F76-8BE8-5E234AE9C330Q35464616-3D5F342D-2046-4F6F-9098-B38A42F18888Q35683209-624D418E-C45E-459D-8F0A-AD7D6AD742DBQ35738923-7D16253F-0627-43F3-9972-E7F0269A58A9Q35790816-7203700E-8612-4D58-A0F8-3A81122DA8E9Q35875363-C95F1E30-5C9E-47DD-A899-9A15F9BCB795Q36326562-9D0A622B-DF2B-4522-81E8-29B77B94278CQ36480698-09B7292D-43A8-45D7-8229-074E7FD0256EQ36662152-1072B06B-A76D-4C6A-AF17-1FD4B2CD2C84Q37049754-8480C6BA-AFBC-49F0-BFE9-B032EB4CE0EFQ37290687-E72D6580-ACB0-49C4-89D9-15F3F8D38A5FQ37368874-50E013F6-9B92-4A65-97E5-B7E3F1375C79Q37427170-AA68D5A5-1968-403C-BB90-490A5528CED5Q37435783-58F68EE1-B04D-4356-861B-55A89DA2D48FQ37639858-A5927A8F-9F4D-4453-9614-2966D7EEB5DEQ37740369-8A6F0FDD-14EA-482A-A793-54CBF7CD066BQ38903993-C22EBF66-7AFB-47EF-BCC8-63B27EC7ECADQ39392202-1499187E-7E4F-4C29-9C74-F63C21DB720DQ40139803-13C15420-BF0A-430A-BB60-C616505B0CD1Q40271425-9F311DBD-F7B2-4E75-AEE0-951AEF4A91ECQ40572648-941DD004-2600-4D84-A01C-8D01A4294D57Q43143047-7A4A091C-9FD2-4E65-B8F9-19CCE07E1794Q44273863-1E61F8AC-9F2A-43E8-BC46-74561159BA91Q45405279-4E0A02A2-2D7B-4C37-B84A-D5A78D155929Q47378700-62AE6DB1-2B83-4644-AAC6-188BFC4496C1Q50903522-D4B8BF06-5D13-4A67-A4A1-CE3F84407636Q51020329-3EA4371D-8F26-4273-AAD3-C8A69BE71FC9Q52598194-F05E7276-AA91-47EB-ACB0-B22449C37A2AQ53141586-8D304F43-C639-4B83-8A53-5A036499ED2CQ53656284-A349FE2D-7670-4463-8EEC-E3C6A01F332BQ54338735-56C48550-1F82-4D45-AEE0-36028C5DAD15
P2860
Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromsø Study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Monocyte count is a predictor ...... at baseline the Tromsø Study.
@en
type
label
Monocyte count is a predictor ...... at baseline the Tromsø Study.
@en
prefLabel
Monocyte count is a predictor ...... at baseline the Tromsø Study.
@en
P2093
P1433
P1476
Monocyte count is a predictor ...... at baseline the Tromsø Study.
@en
P2093
Egil Arnesen
Einar Fosse
Ellisiv B Mathiesen
Eva Stensland-Bugge
Oddmund Joakimsen
Stein Harald Johnsen
P304
P356
10.1161/01.STR.0000158909.07634.83
P407
P577
2005-03-03T00:00:00Z